Warren, RB, A Blauvelt, J Bagel, KA Papp, P Yamauchi, A Armstrong, R Langley, V Vanvoorden, D De Cuyper, L Peterson, N Cross, and K Reich. “Bimekizumab Efficacy and Safety Versus Adalimumab in Patients With Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE)”. SKIN The Journal of Cutaneous Medicine 5, no. 1 (January 1, 2021): s15. Accessed July 20, 2024. https://jofskin.org/index.php/skin/article/view/1168.